- Conditions
- Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +24 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Autoimmune Diseases
Explore clinical trials studying Autoimmune Diseases. Study availability and eligibility vary by location and protocol.
236 public trials
71 recruiting studies
Autoimmune Diseases trial results
Completed
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
NCT01727973
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +11 more
- Locations
-
- Zhongshan Ophthalmic Center Guangzhou, Guangdong, China
NCT01601028
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
- Locations
-
- Seoul National Unversity Hospital Seoul, South Korea
NCT01210716
- Conditions
- Autoimmune Diseases, Blood Protein Disorders, Female Urogenital Diseases, +14 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Virginia Charlottesville, Virginia, United States
- BloodCenter of Wisconsin Milwaukee, Wisconsin, United States
NCT01835457
- Conditions
- Autoimmune Diseases, Bacteremia, Endotoxemia, +8 more
- Locations
-
- Intensive Care Medicine, Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands
Completed
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
NCT01093911
- Conditions
- Autoimmune Diseases, Connective Tissue Disease, Connective Tissue Diseases, +3 more
- Locations
-
- 6 Leuven, Belgium
- 9 Sofia, Bulgaria
- 1 Berlin, Germany
- 2 Erlangen, Germany
NCT01180868
- Conditions
- Autoimmune Diseases, Cancer, Immune System Diseases, +1 more
- Locations
-
- UCLA Los Angeles, California, United States
NCT00817752
- Conditions
- Autoimmune Diseases, Cancer, Immune System Diseases, +4 more
- Locations
-
- Helfgott Research Institute Portland, Oregon, United States
Completed
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
NCT00010387
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +28 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00001291
- Conditions
- Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +18 more
- Locations
-
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States